{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:25:26Z","timestamp":1775539526523,"version":"3.50.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["DP5OD026429"],"award-info":[{"award-number":["DP5OD026429"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Opioid misuse is a public health crisis in the United States. The origin of this crisis is associated with a sharp increase in opioid analgesic prescribing. We used the urban scaling framework to analyze opioid prescribing patterns in US commuting zones (CZs), i.e., groups of counties based on commuting patterns. The urban scaling framework postulates that a set of scaling relations can be used to predict health outcomes and behaviors in cities. We used data from the Drug Enforcement Administration\u2019s Automated Reports and Consolidated Ordering System (ARCOS) to calculate counts of oxycodone\/hydrocodone pills distributed to 607 CZs in the continental US from 2006 to 2014. We estimated the scaling coefficient of opioid pill counts by regressing log(pills) on log(population) using a piecewise linear spline with a single knot at 82,363. Our results show that CZs with populations below the knot scaled superlinearly (\u03b2 = 1.36), i.e., larger CZs had disproportionally larger pill counts compared to smaller CZs. On the other hand, CZs with populations above the knot scaled sublinearly (\u03b2 = 0.92), i.e., larger CZs had disproportionally smaller pill counts compared to smaller CZs. This dual scaling pattern was consistent across US census regions. For CZs with population below the knot, the superlinear scaling of pills is consistent with the explanation that an increased number of successful matches between prescribers and users will lead to higher prescribing rates. The non-linear scaling behavior observed could be the result of a combination of factors, including stronger health care systems and prescribing regulation in largely populated commuting zones, as well as high availability of other opioids such as heroin in these commuting zones. Future research should explore potential mechanisms for the non-linearity of prescription opioid pills.<\/jats:p>","DOI":"10.1371\/journal.pone.0258526","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T23:39:19Z","timestamp":1634081959000},"page":"e0258526","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Urban scaling of opioid analgesic sales in the United States"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4758-3875","authenticated-orcid":true,"given":"Pricila H.","family":"Mullachery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-7773","authenticated-orcid":true,"given":"Usama","family":"Bilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"issue":"6408","key":"pone.0258526.ref001","doi-asserted-by":"crossref","first-page":"eaau1184","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"H Jalal","year":"2018","journal-title":"Science (80-)"},{"key":"pone.0258526.ref002","unstructured":"United States. General Accounting Office. Prescription drugs OxyContin abuse and diversion and efforts to address the problem: report to congressional requesters. 2003."},{"key":"pone.0258526.ref003","first-page":"77","article-title":"The use of opioids for the treatment of chronic pain-A consensus statement from the American Academy of Pain Medicine and the American Pain Society","author":"JD Haddox","year":"1997","journal-title":"Pain Forum"},{"key":"pone.0258526.ref004","unstructured":"The Washington Post. The opioid files: Drilling into the DEA\u2019s pain killer database. 2019;"},{"issue":"10","key":"pone.0258526.ref005","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jpain.2012.07.007","article-title":"Geographic variation in opioid prescribing in the US","volume":"13","author":"DC McDonald","year":"2012","journal-title":"J Pain"},{"issue":"1","key":"pone.0258526.ref006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/add.13543","article-title":"Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas","volume":"112","author":"M Cerd\u00e1","year":"2017","journal-title":"Addiction"},{"issue":"6","key":"pone.0258526.ref007","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","article-title":"Exposing some important barriers to health care access in the rural USA","volume":"129","author":"N Douthit","year":"2015","journal-title":"Public Health"},{"key":"pone.0258526.ref008","first-page":"87","article-title":"Scaling in biology: patterns and processes, causes and consequences","author":"GB West","year":"2000","journal-title":"Scaling Biol"},{"issue":"6139","key":"pone.0258526.ref009","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1126\/science.1235823","article-title":"The origins of scaling in cities","volume":"340","author":"LMA Bettencourt","year":"2013","journal-title":"Science (80-)."},{"issue":"17","key":"pone.0258526.ref010","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1073\/pnas.0610172104","article-title":"Growth, innovation, scaling, and the pace of life in cities","volume":"104","author":"LMA Bettencourt","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"pone.0258526.ref011","doi-asserted-by":"crossref","first-page":"16115","DOI":"10.1103\/PhysRevE.79.016115","article-title":"Superlinear scaling for innovation in cities","volume":"79","author":"S Arbesman","year":"2009","journal-title":"Phys Rev E"},{"issue":"5","key":"pone.0258526.ref012","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s11524-015-9976-x","article-title":"The non-linear health consequences of living in larger cities","volume":"92","author":"LEC Rocha","year":"2015","journal-title":"J Urban Heal"},{"key":"pone.0258526.ref013","unstructured":"Patterson-Lomba O, Gomez-Lievano A. On the scaling patterns of infectious disease incidence in cities. arXiv Prepr arXiv180900277. 2018;"},{"issue":"8","key":"pone.0258526.ref014","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/sextrans-2014-051932","article-title":"Per capita incidence of sexually transmitted infections increases systematically with urban population size: a cross-sectional study","volume":"91","author":"O Patterson-Lomba","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"1","key":"pone.0258526.ref015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1467-9787.2009.00657.x","article-title":"The magnitude and causes of agglomeration economies.","volume":"50","author":"D Puga","year":"2010","journal-title":"J Reg Sci"},{"issue":"2","key":"pone.0258526.ref016","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11113-016-9386-0","article-title":"Reassessing and revising commuting zones for 2010: History, assessment, and updates for US \u2018labor-sheds\u2019 1990\u20132010.","volume":"35","author":"CS Fowler","year":"2016","journal-title":"Popul Res Policy Rev"},{"key":"pone.0258526.ref017","unstructured":"United States. Census Bureau. Intercensal population estimates."},{"issue":"4","key":"pone.0258526.ref018","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1137\/070710111","article-title":"Power-law distributions in empirical data","volume":"51","author":"A Clauset","year":"2009","journal-title":"SIAM Rev"},{"key":"pone.0258526.ref019","unstructured":"United States Census Bureau. 2013 TIGER\/Line Shapefiles (machine readable data files). 2013."},{"issue":"7","key":"pone.0258526.ref020","doi-asserted-by":"crossref","first-page":"150649","DOI":"10.1098\/rsos.150649","article-title":"Is this scaling nonlinear?","volume":"3","author":"JC Leitao","year":"2016","journal-title":"R Soc open Sci"},{"issue":"18","key":"pone.0258526.ref021","first-page":"491","article-title":"Decrease in rate of opioid analgesic overdose deaths\u2014Staten Island, New York City, 2011\u20132013","volume":"64","author":"D Paone","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"pone.0258526.ref022","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida\u2019s prescription drug monitoring program and pill mill laws on opioid prescribing and use","volume":"175","author":"L Rutkow","year":"2015","journal-title":"JAMA Intern Med"},{"key":"pone.0258526.ref023","unstructured":"United States. Drug Enforcement Administration. 2018 National Drug Threat Assessment. Report. 2018."},{"issue":"102","key":"pone.0258526.ref024","doi-asserted-by":"crossref","first-page":"20140745","DOI":"10.1098\/rsif.2014.0745","article-title":"Constructing cities, deconstructing scaling laws","volume":"12","author":"E Arcaute","year":"2015","journal-title":"J R Soc interface"},{"key":"pone.0258526.ref025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.compenvurbsys.2016.04.006","article-title":"Diverse cities or the systematic paradox of urban scaling laws","volume":"63","author":"C Cottineau","year":"2017","journal-title":"Comput Environ Urban Syst"},{"key":"pone.0258526.ref026","author":"B Pardo","year":"2019","journal-title":"Understanding America\u2019s Surge in Fentanyl and Other Synthetic Opioids"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T23:39:50Z","timestamp":1634081990000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258526"}},"subtitle":[],"editor":[{"given":"Nickolas D.","family":"Zaller","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0258526","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}